-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 UIllzOnn6DXRurSMiukW5pQ4JGurzKCp2MVjOA2405ibksSqaH1ktH7I4Z1aaAXc
 8mPEr+YjlCtquAUlNu85wQ==

<SEC-DOCUMENT>0001144204-06-014072.txt : 20061013
<SEC-HEADER>0001144204-06-014072.hdr.sgml : 20061013
<ACCEPTANCE-DATETIME>20060405183505
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001144204-06-014072
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20060405

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MANHATTAN PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001001316
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				363898269
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		810 SEVENTH AVENUE
		STREET 2:		4TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		(212) 582-3950

	MAIL ADDRESS:	
		STREET 1:		810 SEVENTH AVENUE
		STREET 2:		4TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ATLANTIC TECHNOLOGY VENTURES INC
		DATE OF NAME CHANGE:	20000330

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ATLANTIC PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19960703
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
                         MANHATTAN PHARMACEUTICALS, INC.
                          810 SEVENTH AVENUE, 4TH FLOOR
                            NEW YORK, NEW YORK 10019
                                 (212) 582-3950

April 5, 2006

VIA EDGAR AND FACSIMILE (202-772-9217)

U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C.  20549

Attention: Mr. Jeffrey Riedler

         Re:      Manhattan Pharmaceuticals, Inc. (the "Company")
                  Registration Statement on Form S-3
                  File No. 333-131814

Dear Mr. Riedler:

      On behalf of the Company, the undersigned respectfully requests that the
above-referenced Registration Statement be declared effective at 4:00 p.m.,
Washington, D.C. time, on April 7, 2006, or as soon thereafter as is
practicable.

      On behalf of the Company, the undersigned hereby acknowledges the
following:

      1. Should the Commission or the staff, acting pursuant to delegated
authority, declare the filing effective, it does not foreclose the Commission
from taking any action with respect to the filing;

      2. The action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Company from
its full responsibility for the adequacy and accuracy of the disclosure in the
filing; and

      3. The Company may not assert the declaration of effectiveness as a
defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.

                                   Sincerely,

                                   MANHATTAN PHARMACEUTICALS, INC.


                                   By:      /s/ Nicholas J. Rossettos
                                      ------------------------------------------
                                            Nicholas J. Rossettos
                                            Chief Financial Officer

cc:   Mary K. Fraser, Esq. (via facsimile 202-772-9217)
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
